Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07763418
PHASE1

A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess the pharmacokinetics and safety of golcadomide (BMS-986369) in matched healthy participants with normal renal function, adult participants with severe renal impairment, and participants with end-stage renal disease.

Official title: A Phase 1, Multi-center, Single-dose, Open-label Study to Evaluate the Pharmacokinetics and Safety of Golcadomide (BMS-986369) in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

Key Details

Gender

All

Age Range

18 Years - 84 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-09-08

Completion Date

2026-12-28

Last Updated

2026-10-01

Healthy Volunteers

Yes

Interventions

DRUG

Golcadomide

Specified dose on specified days

Locations (3)

Arizona Clinical Trials - Chandler

Chandler, Arizona, United States

Panax Clinical Research

Miami Lakes, Florida, United States

Orlando Clinical Research Center OCRC

Orlando, Florida, United States